Loading…

SOL S.p.A.SOL.MICompetitor analysis, valuation and peers

Italy · EUR·Materials›Chemicals: Specialty

Italian producer and distributor of industrial, medical and specialty gases.

Momentum leader 85
Mkt cap
$6.39B
US dollars, full cap
Free float
37%
of shares outstanding
$/day
$2.64M
20-day average traded
Fwd P/E
30.5×
forward earnings
ROIC−WACC
+1.9 pp
WACC 8.0%
Hurdle
+4 pp
Req g minus delivered
Next earnings
146 days
1 Apr 2027
Close · EUR€62.80
1D-0.6%
1W+5.0%
1M+10.2%
3M+13.2%
6M+6.1%
YTD+28.3%
1Y+29.9%
ATR %2.8%
52w lowhigh2.3% off high

What SOL does

Italian producer and distributor of industrial, medical and specialty gases.

Sells gases under contracts that supply them by pipeline, on-site generators or tanker and cylinder deliveries, so customers pay on an ongoing basis for gas and for the equipment supplied. Healthcare is a second leg, with home-oxygen services paid largely by public health systems. Controlled by Italy's Fumagalli Soldini family.

Products and services

  • Industrial gases (oxygen, nitrogen, argon)
  • Medical gases (hospital oxygen)
  • Home healthcare (oxygen therapy)

Customers

  • Manufacturing/industrial customers, hospitals, hom

Where it sits in the supply chain

  • Materials
  • Specialty chemicals/gases
  • Industrial & medical gas production

What could go right

  • Aging population home healthcare demand
  • Industrial gas demand in manufacturing

What could go wrong

  • Energy cost exposure (gas production is power-intensive)
  • Healthcare reimbursement pricing pressure

Moat: narrow (installed base, regulatory licence, distribution). On-site gas supply contracts and hospital gas infrastructure create long-term customer lock-in.

Headquarters: Monza, Italy · Founded: 1927 · Employees: 7,623

Named competitors

SOL at a glance

Size SOL (SOL.MI) is an Italy Materials company (Chemicals: Specialty) with a market value of $6.39B, the 37th largest of 123 Italy companies the cockpit tracks. Shares closed at €62.80 on 6 Nov 2026.

Performance Over six months the shares gained 6.1%, against -11.8% for the median peer and +3.1% for the Italy market (cap-weighted) — 4th highest of 21 in its peer set.

Growth Revenue grew 8.5% over the last twelve months (peer median +5.1%); the operating margin is 13.7% (peer median 13.8%).

Valuation It trades at 30.5× forward earnings against a peer median of 15.9× (5th most expensive of 20).

Price implies For today's price to make sense, revenue must grow about 17% a year for seven years (Req g). Recent delivered growth is +13%, so the hurdle is +4 pp: the price needs faster growth than the company has been delivering — of companies that just grew 25–50% a year, 93.8% slowed down over the next four years.

Capital Return on invested capital runs 1.9 points above its cost of capital (8.0% WACC).

Next results Next results expected around 1 Apr 2027 (exchange calendar; dates can move).

Relative performance

9010011 May 202611 Aug 20266 Nov 2026SOL.MI 106Peer median 89
Six months, rebased to 100: SOL against the median of its 20 peers (local-currency closes).

SOL financials

Reported figures in EUR; fiscal year ends 2025-12-31. TTM = trailing twelve months.
TTMFY2025FY2024FY2023FY2022
Revenue€1.85B€1.78B€1.61B€1.49B€1.38B
Revenue growth—+10%+8%+8%—
Gross profit€313M€293M€255M€230M€144M
EBITDA€434M€407M€362M€332M€238M
Net income€173M€167M€148M€146M€134M
Free cash flow€72.4M€24.9M€49.9M€78.8M€55.8M
Capital expenditure€262M€270M€246M€205M€161M
Total debtn/a€829M€671M€621M€527M

Quarterly statements and history in the cockpit →

SOL competitor charts

The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.

Performance: 6-month against 1-month return

-20%0%+20%-20%-10%0%+10%NEU600378LINDEINDIA300037CRDA60121601484021600352COROMANDEL300390002601EMNFLUOROCHEM603260MXCEWLK6004264005SOL.MI6-month return →1-month return →
Up and to the right = strong over both horizons. SOL is the large dot.

Fundamentals: revenue growth against valuation

0%+25%+50%+75%+100%0×50×100×600378LINDEINDIA300037CRDA60121601484021600352COROMANDEL300390FLUOROCHEM603260MXCEWLKSOL.MIRevenue growth (TTM) →Forward P/E →
Further right = faster growth; higher = more expensive. The dashed lines are the peer medians. SOL is the large dot.

Capital: growth delivered against growth the price implies

0%+20%+40%0%20%40%NEU600378LINDEINDIA300037CRDA6012164021600352002601EMN603260MXWLK6004264005SOL.MIGrowth delivered (Del g) →Growth the price implies (Req g, 7 yrs) →
Above the diagonal = the price needs more growth than the company has been delivering; below = the price already allows for a slowdown. SOL is the large dot.

SOL competitors and peer comparison

Head to head with its named competitors (SOL.MI vs AI.PA vs LIN vs 4091.T)
CompanyMarket cap6M returnRevenue growthOp. marginForward P/EReq g
SOL SOL.MI$6.39B+6%+9%14%30.5×16.9%
Air Liquide AI.PA$134B+15%-1%21%29.0×18.1%
Linde LIN$237B+5%+8%27%27.0×14.4%
Nippon Sanso 4091.T$15.3B+1%+10%15%16.9×7.8%

How SOL compares with its peers

Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.

SOL against its 20 peers (data as of 6 Nov 2026)
MeasureSOL.MIPeer medianRank in peer set
1-month return+10.2%-0.4%2nd highest of 21
6-month return+6.1%-11.8%4th highest of 21
Distance from 52-week high-2.3%-31.2%highest of 21
Revenue growth (TTM)+8.5%+5.1%10th highest of 21
Operating margin13.7%13.8%11th highest of 21
Forward P/E30.5×15.9×5th most expensive of 20
Growth the price implies (Req g, 7 yrs)16.9%5.2%6th most demanding of 17
Growth delivered (Del g)+12.8%+9.7%6th highest of 17
Hurdle (Req g minus delivered)+4.2 pp-3.9 pp5th most demanding of 17
ROIC minus cost of capital+1.9 pp-0.7 pp7th highest of 21
EV / EBITDA14.5×10.1×4th most expensive of 13
Net debt / EBITDA1.3×1.4×5th least indebted of 13

Peer table

Peer set: Industry: the same industry and sector in any market, nearest in size
CompanyMarketMarket cap6M returnRevenue growthOp. marginForward P/EReq gDelivered g
SOL SOL.MIItaly$6.39B+6%+9%14%30.5×16.9%+12.8%
NewMarket NEUUnited States$6.39B+1%+1%20%n/a-0.8%+6.3%
Haohua Chemical Science & Technology 600378.SSChina$6.29B-9%+20%9%22.1×11.0%+25.2%
Linde India LINDEINDIA.NSIndia$6.20B-13%+13%22%97.2×47.9%+11.5%
Shenzhen Capchem Technology 300037.SZChina$6.16B-21%+72%13%19.0×19.3%+26.6%
Croda International CRDA.LUnited Kingdom$6.88B+31%+3%16%23.3×19.9%+4.1%
Inner Mongolia Junzheng Energy & Chemical 601216.SSChina$5.92B-16%+3%11%12.0×-3.4%+11.3%
Kingboard 0148.HKHong Kong$5.78B-17%+19%15%5.0×n/an/a
Nissan Chemical 4021.TJapan$5.72B0%+10%23%15.9×9.3%+6.0%
Zhejiang Longsheng 600352.SSChina$5.70B-11%-1%19%13.7×-5.2%-3.1%
Coromandel International COROMANDEL.NSIndia$5.69B-7%+24%8%27.3×n/an/a
Canmax Technologies 300390.SZChina$5.62B-64%+98%27%7.3×n/an/a
LB Group Co., Ltd. Class A 002601.SZChina$5.58B-8%+7%7%22.4×5.0%+12.9%
Eastman Chemical EMNUnited States$7.37B-13%0%10%10.2×5.1%+0.7%
Gujarat Fluorochemicals FLUOROCHEM.NSIndia$5.42B+23%+20%17%53.0×n/an/a
Hoshine Silicon Industry 603260.SSChina$5.32B-33%-7%-6%41.7×22.5%+18.5%
Methanex MX.TOCanada$5.18B+12%+31%23%6.9×-9.4%+7.1%
Celanese CEUnited States$5.10B-19%+1%9%7.6×5.3%+11.0%
Westlake WLKUnited States$8.11B-32%0%1%38.6×37.4%+8.3%
Shandong Hualu-Hengsheng Chemical 600426.SSChina$8.27B-32%+3%16%12.3×-2.5%+18.7%
Sumitomo Chemical 4005.TJapan$4.93B-7%-2%5%6.9×1.1%+0.4%

Questions

Who are SOL's main competitors?
Named competitors: Air Liquide (AI.PA), Linde (LIN), Nippon Sanso Holdings (4091.T). The cockpit's measured peer set (industry) also includes NewMarket (NEU), Haohua Chemical Science & Technology (600378.SS), Linde India (LINDEINDIA.NS), Shenzhen Capchem Technology (300037.SZ), Croda International (CRDA.L), Inner Mongolia Junzheng Energy & Chemical (601216.SS).
Is SOL expensive compared with its peers?
On forward p/e it trades at 30.5× against a peer median of 15.9×, 5th most expensive of 20 in its peer set. For today's price to make sense, revenue must grow about 17% a year for seven years (Req g). Recent delivered growth is +13%, so the hurdle is +4 pp: the price needs faster growth than the company has been delivering — of companies that just grew 25–50% a year, 93.8% slowed down over the next four years.
How has SOL stock performed?
Over six months to 6 Nov 2026 the shares returned +6.1% against -11.8% for the median peer; over one year +29.9%.

How these numbers are made. Returns are close-to-close in local currency. Revenue growth and margins are trailing twelve months. Req g is the revenue growth that today's enterprise value requires for seven years at the company's own cost of capital; Delivered g is what it actually grew; the gap is the hurdle (honest precision about ±8 points, so read the ranking more than the decimal). No fair values, price targets or analyst ratings are shown, by design. Method and validation.